Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 23(3): 798-806, 2003 Feb 01.
Article in English | MEDLINE | ID: mdl-12574408

ABSTRACT

Dynamic regulation of the number and activity of AMPA receptors is believed to underlie many forms of synaptic plasticity and is presumably mediated by specific protein-protein interactions involving the C-terminal domain of the receptor. Several proteins interacting with the C-terminal tails of the glutamate receptor (GluR)-A and GluR-B subunits have been identified and implicated in the regulation of endocytosis and exocytosis, clustering, and anchoring of AMPA receptors to the cytoskeleton. In contrast, little is known of the molecular interactions of the GluR-D subunit, or of the mechanisms regulating the traffic of GluR-D-containing AMPA receptors. We analyzed the subcellular localization of homomeric GluR-D receptors carrying C-terminal deletions in transfected human embryonic kidney (HEK) 293 cells and in primary neurons by immunofluorescence microscopy and ELISA. A minimal requirement for a 14-residue cytoplasmic segment for the surface expression of homomeric GluR-D receptors was identified. Previously, a similar region in the GluR-A subunit was implicated in an interaction with 4.1 family proteins. Coimmunoprecipitation demonstrated that GluR-D associated with 4.1 protein(s) in both HEK293 cells and rat brain. Moreover, glutathione S-transferase pull-down experiments showed that the same 14-residue segment is critical for 4.1 binding to GluR-A and GluR-D. Point mutations within this segment dramatically decreased the surface expression of GluR-D in HEK293 cells, with a concomitant loss of the 4.1 interaction. Our findings demonstrate a novel molecular interaction for the GluR-D subunit and suggest that the association with the 4.1 family protein(s) plays an essential role in the transport to and stabilization of GluR-D-containing AMPA receptors at the cell surface.


Subject(s)
Cell Membrane/metabolism , Cytoskeletal Proteins/metabolism , Membrane Proteins , Neuropeptides/metabolism , Receptors, AMPA/metabolism , Receptors, Glutamate/metabolism , Amino Acid Substitution/physiology , Cells, Cultured , Hippocampus/cytology , Kidney/cytology , Kidney/metabolism , Mutagenesis, Site-Directed , Neurons/cytology , Neurons/metabolism , Protein Binding/physiology , Protein Structure, Tertiary/physiology , Proteins/metabolism , Receptors, AMPA/genetics , Receptors, Glutamate/genetics , Sequence Deletion , Transfection
2.
Eur J Biochem ; 269(24): 6261-70, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12473122

ABSTRACT

Previous structural and mutagenesis studies indicate that the invariant alpha-amino and alpha-carboxyl groups of glutamate receptor agonists are engaged in polar interactions with oppositely charged, conserved arginine and glutamate residues in the ligand-binding domain of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor. To examine the role of these residues (R507 and E727 in the GluR-D subunit) in the discrimination between agonists and antagonists, we analyzed the ligand-binding properties of homomeric GluR-D and its soluble ligand-binding domain with mutations at these positions. Filter-binding assays using [3H]AMPA, an agonist, and [3H]Ro 48-8587, a high-affinity antagonist, as radioligands revealed that even a conservative mutation at R507 (R507K) resulted in the complete loss of both agonist and antagonist binding. In contrast, a negative charge at position 727 was necessary for agonist binding, whereas the isosteric mutation, E727Q, abolished all agonist binding but retained high-affinity binding for [3H]Ro 48-8587, displaceable by 7,8-dinitroquinoxaline-2,3-dione. Competition binding studies with antagonists representing different structural classes in combination with ligand docking experiments suggest that the role of E727 is antagonist-specific, ranging from no interaction to weak electrostatic interactions involving indirect and direct hydrogen bonding with the antagonist molecule. These results underline the importance of ion pair interaction with E727 for agonist activity and suggest that an interaction with R507, but not with E727, is essential for antagonist binding.


Subject(s)
Receptors, Glutamate/chemistry , Receptors, Glutamate/metabolism , Animals , Arginine/chemistry , Binding Sites , Blotting, Western , Cell Membrane/metabolism , Dose-Response Relationship, Drug , Glutamic Acid/chemistry , Imidazoles/pharmacology , Kinetics , Ligands , Models, Chemical , Models, Molecular , Mutagenesis, Site-Directed , Mutation , Point Mutation , Protein Binding , Protein Conformation , Protein Structure, Tertiary , Quinazolines/pharmacology , Rats , Receptors, Glutamate/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...